Search by Drug Name or NDC

    NDC 57664-0379-88 Dexmethylphenidate hydrochloride 10 mg/1 Details

    Dexmethylphenidate hydrochloride 10 mg/1

    Dexmethylphenidate hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is DEXMETHYLPHENIDATE HYDROCHLORIDE.

    Product Information

    NDC 57664-0379
    Product ID 57664-379_0d0cbfc3-ae27-b481-e063-6394a90a917c
    Associated GPIs 61400016100340
    GCN Sequence Number 048984
    GCN Sequence Number Description dexmethylphenidate HCl TABLET 10 MG ORAL
    HIC3 H2V
    HIC3 Description TX FOR ATTENTION DEFICIT-HYPERACT(ADHD)/NARCOLEPSY
    GCN 14975
    HICL Sequence Number 022987
    HICL Sequence Number Description DEXMETHYLPHENIDATE HCL
    Brand/Generic Generic
    Proprietary Name Dexmethylphenidate hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dexmethylphenidate hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name DEXMETHYLPHENIDATE HYDROCHLORIDE
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA201231
    Listing Certified Through 2025-12-31

    Package

    NDC 57664-0379-88 (57664037988)

    NDC Package Code 57664-379-88
    Billing NDC 57664037988
    Package 100 TABLET in 1 BOTTLE (57664-379-88)
    Marketing Start Date 2013-09-26
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.33016
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DEXMETHYLPHENIDATE 10 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis